Wells Fargo’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8K | Sell |
10,012
-1
| -0% | -$4 | ﹤0.01% | 5193 |
|
|
2025
Q1 | $21.5K | Hold |
10,013
| – | – | ﹤0.01% | 5231 |
|
|
2024
Q4 | $30.5K | Hold |
10,013
| – | – | ﹤0.01% | 5143 |
|
|
2024
Q3 | $23.1K | Hold |
10,013
| – | – | ﹤0.01% | 5202 |
|
|
2024
Q2 | $28.3K | Sell |
10,013
-11
| -0.1% | -$31 | ﹤0.01% | 5115 |
|
|
2024
Q1 | $44.4K | Hold |
10,024
| – | – | ﹤0.01% | 4927 |
|
|
2023
Q4 | $76.7K | Buy |
10,024
+1
| +0% | +$8 | ﹤0.01% | 4658 |
|
|
2023
Q3 | $72.5K | Buy |
10,023
+6,670
| +199% | +$48.2K | ﹤0.01% | 4626 |
|
|
2023
Q2 | $31.4K | Buy |
3,353
+1
| +0% | +$9 | ﹤0.01% | 5317 |
|
|
2023
Q1 | $55.3K | Hold |
3,352
| – | – | ﹤0.01% | 4829 |
|
|
2022
Q4 | $89.1K | Buy |
3,352
+3,334
| +18,522% | +$88.6K | ﹤0.01% | 4301 |
|
|
2022
Q3 | $1K | Sell |
18
-2
| -10% | -$111 | ﹤0.01% | 6018 |
|
|
2022
Q2 | $2K | Sell |
20
-988
| -98% | -$98.8K | ﹤0.01% | 6023 |
|
|
2022
Q1 | $87K | Buy |
1,008
+653
| +184% | +$56.4K | ﹤0.01% | 5074 |
|
|
2021
Q4 | $32K | Buy |
355
+296
| +502% | +$26.7K | ﹤0.01% | 5682 |
|
|
2021
Q3 | $13K | Buy |
59
+46
| +354% | +$10.1K | ﹤0.01% | 5786 |
|
|
2021
Q2 | $6K | Buy |
13
+9
| +225% | +$4.15K | ﹤0.01% | 5944 |
|
|
2021
Q1 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 6345 |
|